IONIS PHARMACEUTICALS INC - COM (IONS)

Historical Portfolio Holders from Q4 2015 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
155M
Holdings value Q3 2024
$6.22B
Value change Q3 2024
+$421M
Grand Portfolio weight change Q3 2024
+0.001%
Number of holders
345
Number of buys Q3 2024
174
Number of sells Q3 2024
-158
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 155M $6.22B +$421M $40.06 348
2024 Q2 143M $6.82B +$110M $47.66 355
2024 Q1 141M $6.09B -$77.5M $43.35 350
2023 Q4 142M $7.2B +$146M $50.59 359
2023 Q3 139M $6.28B +$131M $45.36 308
2023 Q2 136M $5.56B +$219M $41.03 300
2023 Q1 130M $4.66B +$28.9M $35.74 305
2022 Q4 130M $4.89B +$160M $37.77 332
2022 Q3 125M $5.54B -$406M $44.23 336
2022 Q2 123M $4.57B +$11.2M $37.02 330
2022 Q1 124M $4.58B +$93.8M $37.04 313
2021 Q4 122M $3.71B +$12.5M $30.43 320
2021 Q3 121M $4.04B -$99.8M $33.54 303
2021 Q2 123M $4.91B +$71.5M $39.89 321
2021 Q1 122M $5.49B +$79.5M $44.96 346
2020 Q4 120M $6.79B +$106M $56.54 366
2020 Q3 118M $5.62B -$83.5M $47.45 351
2020 Q2 120M $7.08B +$119M $58.96 363
2020 Q1 118M $5.58B -$141M $47.28 345
2019 Q4 121M $7.29B -$84.8M $60.41 375
2019 Q3 122M $7.3B -$290M $59.91 360
2019 Q2 127M $8.13B +$1.22B $64.27 384
2019 Q1 117M $9.51B -$4.38M $81.17 388
2018 Q4 118M $6.36B -$40.8M $54.06 316
2018 Q3 118M $6.1B +$13.1M $51.58 312
2018 Q2 118M $4.93B +$130M $41.67 298
2018 Q1 115M $5.07B +$57M $44.08 320
2017 Q4 114M $5.72B -$67.8M $50.30 312
2017 Q3 115M $5.84B +$169M $50.70 295
2017 Q2 111M $5.64B +$56.1M $50.87 286
2017 Q1 111M $4.44B +$327M $40.20 265
2016 Q4 108M $5.17B +$130M $47.83 300
2016 Q3 106M $3.89B -$67.8M $36.64 269
2016 Q2 109M $2.53B +$26.4M $23.29 269
2016 Q1 105M $4.26B +$20.9M $40.50 308
2015 Q4 103M $6.39B +$6.39B $61.93 330